OtherInvited Commentary
PET Imaging with 18F-FLT and Thymidine Analogs: Promise and Pitfalls
Anthony F. Shields
Journal of Nuclear Medicine September 2003, 44 (9) 1432-1434;
In this issue
PET Imaging with 18F-FLT and Thymidine Analogs: Promise and Pitfalls
Anthony F. Shields
Journal of Nuclear Medicine Sep 2003, 44 (9) 1432-1434;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Utilizing novel fluorothymidine PET imaging in a phase I study of veliparib on an intermittent and continuous schedule given in combination with carboplatin in metastatic breast cancer
- [18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity
- The Use of Novel PET Tracers to Image Breast Cancer Biologic Processes Such as Proliferation, DNA Damage and Repair, and Angiogenesis
- 3'-Deoxy-3'-18F-Fluorothymidine PET Predicts Response to V600EBRAF-Targeted Therapy in Preclinical Models of Colorectal Cancer
- Assessment of Cellular Proliferation in Tumors by PET Using 18F-ISO-1
- Structure-guided Engineering of Human Thymidine Kinase 2 as a Positron Emission Tomography Reporter Gene for Enhanced Phosphorylation of Non-natural Thymidine Analog Reporter Probe
- Changes in 18F-Fluorodeoxyglucose and 18F-Fluorodeoxythymidine Positron Emission Tomography Imaging in Patients with Non-Small Cell Lung Cancer Treated with Erlotinib
- Different Modes of Transport for 3H-Thymidine, 3H-FLT, and 3H-FMAU in Proliferating and Nonproliferating Human Tumor Cells
- Kinetics of 3'-Deoxy-3'-18F-Fluorothymidine During Treatment Monitoring of Recurrent High-Grade Glioma
- PET Monitoring of Therapy Response in Head and Neck Squamous Cell Carcinoma
- Molecular Imaging In Tumor Treatment Response
- Imaging Surrogates of Tumor Response to Therapy: Anatomic and Functional Biomarkers
- Preferential Tumor Targeting and Selective Tumor Cell Cytotoxicity of 5-[131/125I]Iodo-4'-Thio-2'-Deoxyuridine
- The role of clinical imaging in oncological drug development
- Imaging and Oncologic Drug Development
- Synthesis and In Vivo Evaluation of 2 High-Affinity 76Br-Labeled {sigma}2-Receptor Ligands
- The Progress and Promise of Molecular Imaging Probes in Oncologic Drug Development